Related Experiment Video
Updated: Jan 7, 2026

06:19
Constructing and Visualizing Models using Mime-based Machine-learning Framework
Published on: July 22, 2025
2.2K
From Classical Machine Learning to Emerging Foundation Models: Review on Multimodal Data Integration for Cancer
Arxiv
|December 25, 2025
Summary
Foundation models (FMs) are revolutionizing cancer research by integrating diverse data types. This review maps the shift from traditional machine learning to FMs for multimodal data integration in oncology, paving the way for AI-driven discoveries.
Area of Science:
- Computational oncology
- Artificial intelligence in medicine
- Multimodal data integration
Background:
- Cancer research increasingly relies on integrating diverse data modalities like genomics, proteomics, imaging, and clinical data.
- Extracting actionable insights from these complex, heterogeneous datasets presents a significant challenge.
- Foundation models (FMs) offer promising avenues for biomarker discovery, improved diagnostics, and personalized cancer treatment.
Purpose of the Study:
- To provide a comprehensive review of multimodal data integration strategies in oncology.
- To examine emerging trends in machine learning (ML) and deep learning (DL), focusing on the transition to FMs.
- To identify state-of-the-art FMs, repositories, and tools for advancing data-driven cancer research.
Main Methods:
- Systematic review of literature on multimodal data integration in oncology.
- Analysis of machine learning (ML) and deep learning (DL) methodologies, including foundation models (FMs).
- Examination of trends, frameworks, validation protocols, and open-source resources.
Main Results:
- The study maps the transition from conventional ML to advanced FMs for multimodal data integration in oncology.
- Identifies key advancements, challenges, and state-of-the-art FMs for integrating multi-omics and imaging data.
- Highlights publicly available multimodal repositories and tools crucial for data integration.
Conclusions:
- Current integrative methods using FMs lay the groundwork for next-generation large-scale AI models in oncology.
- This review is the first to systematically chart the evolution from ML to FMs in multimodal cancer data integration.
- These advancements are foundational for the future of AI-driven cancer research and personalized medicine.
Related Concept Videos
Mouse Models of Cancer Study
6.3K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.3K
Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K

